We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
-2.15%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$141M
AUM Growth
-$10.2M
Cap. Flow
-$4.64M
Cap. Flow %
-3.29%
Top 10 Hldgs %
58.1%
Holding
48
New
Increased
7
Reduced
41
Closed

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$15.9K
2
LLY icon
Eli Lilly
LLY
+$12.3K
3
DUK icon
Duke Energy
DUK
+$7.66K
4
NEE icon
NextEra Energy
NEE
+$7.17K
5
VZ icon
Verizon
VZ
+$5.75K

Top Sells

Rank Stock Value
1
CTSH icon
Cognizant
CTSH
+$529K
2
PRLB icon
Protolabs
PRLB
+$453K
3
AAPL icon
Apple
AAPL
+$415K
4
CELG
Celgene Corp
CELG
+$298K
5
BIDU icon
Baidu
BIDU
+$295K

Sector Composition

Rank Sector Weight
1 Healthcare 33.47%
2 Consumer Discretionary 26.82%
3 Technology 22.39%
4 Communication Services 12.4%
5 Industrials 2.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.95T
$16.7M 11.85%
577,728
-14,636
-2% -$415K
CELG
2
DELISTED
Celgene Corp
CELG
$9.98M 7.07%
86,200
-2,676
-3% -$298K
ISRG icon
3
Intuitive Surgical
ISRG
$128B
$8.64M 6.12%
122,634
-3,465
-3% -$255K
ULTA icon
4
Ulta Beauty
ULTA
$20.7B
$7.85M 5.56%
30,774
-589
-2% -$147K
ILMN icon
5
Illumina
ILMN
$28.7B
$7.35M 5.21%
59,029
-1,707
-3% -$230K
GILD icon
6
Gilead Sciences
GILD
$162B
$6.95M 4.92%
97,004
-1,883
-2% -$140K
AMZN icon
7
Amazon
AMZN
$2.49T
$6.62M 4.69%
176,560
-2,920
-2% -$114K
META icon
8
Meta Platforms (Facebook)
META
$1.51T
$6.61M 4.68%
57,408
-1,143
-2% -$140K
CTSH icon
9
Cognizant
CTSH
$22.3B
$5.79M 4.1%
103,325
-9,880
-9% -$529K
LULU icon
10
lululemon athletica
LULU
$13.4B
$5.52M 3.91%
84,984
-2,005
-2% -$120K
CAVM
11
DELISTED
Cavium, Inc.
CAVM
$4.89M 3.47%
78,396
-2,630
-3% -$152K
VIPS icon
12
Vipshop
VIPS
$7.08B
$4.23M 2.99%
223,084
-13,595
-6% -$176K
GOOG icon
13
Alphabet (Google) Class C
GOOG
$3.99T
$4.22M 2.99%
109,300
-2,800
-2% -$109K
SBUX icon
14
Starbucks
SBUX
$118B
$4.11M 2.91%
74,092
-1,986
-3% -$110K
ALXN
15
DELISTED
Alexion Pharmaceuticals
ALXN
$4.08M 2.89%
33,349
-634
-2% -$77.6K
BKNG icon
16
Booking.com
BKNG
$145B
$4.07M 2.88%
69,350
-1,075
-2% -$64.2K
ABBV icon
17
AbbVie
ABBV
$454B
$3.78M 2.68%
60,312
-1,130
-2% -$69K
MELI icon
18
Mercado Libre
MELI
$92.3B
$3.76M 2.66%
24,088
-400
-2% -$66.1K
VMW
19
DELISTED
VMware, Inc
VMW
$3.67M 2.6%
46,656
-1,020
-2% -$79.2K
GOOGL icon
20
Alphabet (Google) Class A
GOOGL
$3.99T
$3.27M 2.32%
82,540
-4,460
-5% -$178K
BIIB icon
21
Biogen
BIIB
$29.5B
$2.68M 1.9%
9,458
-423
-4% -$125K
BIDU icon
22
Baidu
BIDU
$35.8B
$2.5M 1.77%
15,220
-1,736
-10% -$295K
PRLB icon
23
Protolabs
PRLB
$1.85B
$1.71M 1.21%
33,267
-8,638
-21% -$453K
KMI icon
24
Kinder Morgan
KMI
$70.6B
$967K 0.69%
46,713
-1,880
-4% -$39.7K
HD icon
25
Home Depot
HD
$335B
$846K 0.6%
6,310
-180
-3% -$23.2K

Similar funds

Bender Robert & Associates's Q4 2016 Portfolio in Review

As of Q4 2016, Bender Robert & Associates held 48 positions worth $141M, down 6.7% from $151M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Bender Robert & Associates withdrew a net $4.64M in Q4 2016, reducing 41 holdings. Its largest reduction was Cognizant, cutting an estimated $529K.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Bender Robert & Associates added an estimated $15.9K to Bristol-Myers Squibb.

  • Bender Robert & Associates added most to Bristol-Myers Squibb in Q4 2016, an estimated $15.9K increase.
  • Bender Robert & Associates's biggest Q4 2016 reduction was Cognizant, cutting an estimated $529K.
  • Bender Robert & Associates's ten largest holdings make up 58% of its $141M portfolio in Q4 2016.
  • Bender Robert & Associates opened 0 new positions and closed 0 in Q4 2016.
  • Bender Robert & Associates's portfolio value fell 6.7% quarter-over-quarter to $141M.

Based on Bender Robert & Associates's 13F filing for Q4 2016, filed 26 Jan 2017.